Total: $1,045.1M

Company (Symbol)#

Type Of Financing

Number Of Shares, Units Or Warrants (M)

Amount Raised (M)

Investors; Placement Agents; Details (Date)@

AEterna Laboratories Inc. (AELA; TSE:AEL)

Private placement of common stock and warrants

7.57S and 7.43W

C$57
(US$35.7)

AEterna raised US$35.7M in two private placements, one with SGF Sante and Solidarity Fund QFL, and the other with Acqua Wellington Private Placement Fund Ltd.; the first one involved 7.3M shares and 7.3M warrants; the second one involved about 270,000 shares and about 133,000 warrants (4/9)

Allos Therapeutics Inc. (ALTH)

Private placement of common stock

2.5S

$15

Allos raised $15M in a private placement with Perseus-Soros Pharmaceutical Fund LP (4/24)

Bioniche Pharma Group Ltd. (unit of Bioniche Life Sciences Inc.; Canada; TSE:BNC)

Private placement of a convertible debenture

N/A

C$1.8
(US$1.1)

Bioniche Pharma received US$1.1M from ICC Venture Capital in the form of a 6% convertible debenture (4/24**)

Biopure Corp. (BPUR)

Private placement of common stock

2.8S

$20.7

Biopure raised about $20.7M with the placement of 2.8M shares with institutional investors (4/24)

Genaera Corp. (GENR)

Private placement of common stock

6S

$16.5

Genaera raised $16.5M in a private placement with institutional investors (4/9)

Hyseq Pharmaceuticals Inc. (HYSQ)

Private placement of common stock

3.58S

$15

Hyseq raised $15M in a private placement with undisclosed accredited investors (4/9)

IDEC Pharmaceuticals Corp. (IDPH)

Private placement of senior convertible notes

Convertible into 8.2S

$675

IDEC expects to gross $675M with the placement of notes that are convertible into 8.2M shares, or 9.1M shares if the overallotment option is exercised in full; the notes were offered to institutional buyers (4/24)

Isis Pharmaceuticals Inc. (ISIP)

Private placement of convertible subordinated notes

ND

$125

Isis raised $125M in the placement of notes, which are convertible into shares at $16.625 per share (4/26)

Ligand Pharmaceuticals Inc. (LGND)

Private placement of common stock

4.25S

$69.3

Ligand raised $69.3M in a private placement of 4.25M shares (4/17)

Lynx Therapeutics Inc. (LYNX)

Private placement of common stock

14.6S and W for 5.8S

$22.6

Lynx raised $22.6M in a private placement of 14.6M shares, as well as warrants for 5.8M shares (4/18)

Nymox Pharmaceuticals Corp. (NYMX)

Private placement of common stock

N/A

$0.819

Nymox raised $819,000 through a private placement with existing shareholders (4/3)

Senesco Technologies Inc. (OTC BB: SENO)

Private placement of common stock and warrants

N/A

$3.48

Senesco raised $3.48M through a private placement with certain accredited investors (4/24)

Versicor Inc. (VERS)

Private placement of common stock

3S

$44.9

Versicor raised $44.9M in a private placement (4/11)

Notes:

# Unless otherwise indicated, shares are traded on the Nasdaq exchange. This chart does not include real estate or manufacturing plant financings.

@ Dates refer to the date of the press release.

** Denotes the date the item ran in BioWorld International.

N/A = Not available, applicable or reported.

OTC BB = Over the Counter Bulletin Board; TSE = Toronto Stock Exchange

No Comments